Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus INPERSOL LC LM W DEXTROSE 3 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus INPERSOL LC LM W DEXTROSE 3 5 IN PLASTIC CONTAINER.
DIANEAL LOW CALCIUM W/DEXTROSE 1.5% IN PLASTIC CONTAINER vs INPERSOL-LC/LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dianeal Low Calcium with Dextrose 1.5% is a peritoneal dialysis solution that provides osmotic gradient for ultrafiltration and diffusion of solutes across the peritoneal membrane. Dextrose (1.5%) acts as the osmotic agent, creating a concentration gradient that drives water removal. The low calcium concentration (2.5 mEq/L) helps manage hypercalcemia in patients requiring calcium-based phosphate binders.
Inpersol-LC/LM with 3.5% dextrose is a peritoneal dialysis solution that provides osmotic ultrafiltration via dextrose, removing waste products and excess fluid from the blood across the peritoneal membrane. The low calcium (LC) and low magnesium (LM) formulations adjust electrolyte concentrations to manage imbalances.
Intraperitoneal administration: 2 L per exchange, 4 exchanges per day (2.5 L per exchange for larger patients if tolerated).
Intraperitoneal administration: 2 to 2.5 liters per exchange, 4 to 5 exchanges per day, as prescribed by physician based on peritoneal equilibration test.
None Documented
None Documented
For intraperitoneal dextrose: not clinically applicable as elimination is via continuous peritoneal dialysis. Systemically absorbed dextrose has a half-life of 15-20 minutes due to rapid cellular uptake and metabolism.
Not applicable; dextrose is continuously infused and removed; the half-life of intraperitoneal dextrose is approximately 1-2 hours due to rapid absorption and metabolism, with clinically relevant hyperglycemia managed by insulin.
Primarily removed via peritoneal dialysis itself; ~70% of absorbed glucose undergoes metabolism, with remaining glucose and lactate absorbed systemically and metabolized hepatically. Renal elimination of dextrose and lactate is negligible (<5%) due to low systemic absorption and endogenous metabolism.
Renal (via peritoneal dialysis effluent); approximately 60-70% of administered dextrose is absorbed and metabolized, with the remainder removed in dialysate; no significant biliary/fecal elimination.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution